You don't have to sit in a self-driving Tesla to feel the impact of artificial intelligence (AI) on your daily life. From voice-powered personal assistants like Alexa or Siri to help you track and organize information to tailored online shopping, AI is no longer in the realm of science fiction.
Machine-learning platforms for clinical purposes are also making the headlines. Early last year, Stanford-based scientists harnessed a Google algorithm to classify skin cancers as accurately as board-certified dermatologists (Esteva et al., 2017) . This algorithm distinguishes harmless from potentially fatal moles at an early stage, which is critical, given that melanoma is one of the deadliest cancers and its global incidence is on the rise. 2018 itself has already seen significant AI advances. These bring many unprecedented opportunities-and daunting challenges.
''The eyes are a window to the heart''-we've all heard it before. While popular sayings are not meant to be taken literally, recent research suggests there may be some truth to this one. In collaboration with the Stanford School of Medicine, Google and its sister company, Verily Life Sciences, recently reported a deep-learning model that can recognize elevated cardiovascular disease risk from photographs of the retinal fundus (Poplin et al., 2018) . Around the same time, a team of scientists from the University of California, San Diego, and Guangzhou University described an AI platform for the screening and diagnosis of common causes of severe vision loss at a stage where the diseases are still treatable. Further, the authors demonstrated the general applicability of their machine-learning system by showing its potential for diagnosing pediatric pneumonia using chest X-rays (Kermany et al., 2018) . Last month, a paper published in Nature Digital Medicine reported that computer vision can also be leveraged to interpret echocardiograms and does so at accuracies that exceed those of trained experts (Madani et al., 2018) . While these developments nicely illustrate the potential for AI in imaged-based medical diagnosis, they are not completely unanticipated. It is well accepted that machines can be fed large amounts of data and be trained to recognize patterns much better than humans. What is surprising is the speed with which such potential is now being unleashed.
Medical regulators have also started to open the doors for machine-learning algorithms. Earlier this year, the U.S. Food and Drug Administration (FDA) cleared the healthcare company Viz to market its deep-learning technology to doctors and hospitals. The application in question, LVO Stroke System, uses an AI algorithm to analyze brain computed tomography (CT) scans from patients and sends a text notification to a neurovascular specialist if indicators associated with a stroke are detected. When brain cells start to suffer as a result of a stroke, the race against the clock begins. Earlier intervention can significantly decrease the extent of the damage and prevent disability. The approval of the Viz application is a step toward making healthcare more proficient and cost effective, but it was not the first time the FDA embraced this new era of intelligent care. In January 2017, the medical regulator approved for the first time the marketing of a machine learning application: Cardio DL from Arterys for diagnosing heart problems. Over the past year, several other applications were also granted FDA-marketing clearances, including a predictive platform that calculates the risk of patient deterioration to avoid unexpected deaths in hospitals and a smart watch designed to identify and monitor epileptic seizures. These and other recent FDA clearances are in line with the regulator's effort to reform its approach to digital health regulation to encourage innovation and modernization. Some of these products have also obtained permission for commercialization in Europe, setting the stage for a worldwide competitive market for AI in healthcare.
Deep learning also holds great potential for improving healthcare in remote communities and third-world countries, where medical resources are scarce. In fact, implementing AI in rural areas could have much more immediate impact for saving lives than in wealthier countries, so the benefits may easily outweigh the risks.
While the question may no longer be whether AI will revolutionize the current health care system, but rather when and at what cost, one needs to beware of the AI hype too. In a time where the speed of medical science sometimes seems excruciatingly slow with technological, bureaucratic, and legal obstacles, the vibrant and fast-moving field of medical AI may feel like the promise of a blooming spring after a long Boston winter. But it's important to acknowledge and discuss the limitations too. For instance, a proof-of-concept study published in JAMA Cardiology last month reported that a commercially available smartwatch can be coupled with a deep neural network to detect atrial fibrillation, which is a leading cause of stroke (Tison et al., 2018) . While promising, further studies are required for optimizing this platform for rhythm assessment. Yet, despite the reported ''moderate accuracy'' and the author's indication for the need of improvement, this development has been widely covered by the media and reported as a major success.
What will it take to successfully translate AI platforms into wide clinical practice? Trusting Siri for restaurant recommendations is one thing, but should we rely on AI for important medical decisions? Platforms that provide transparent and interpretable explanations for the underlying complex computational steps will be essential for generating trust and acceptance from both healthcare providers and patients.
Regardless of how, when, and where AI is implemented, there will be substantial social consequences to this. Regulatory agencies currently demand that AI applications perform at least as well as experienced physicians, but as the field develops, expectations for AI performance will inevitably become higher and higher. Machines already outperform humans in many different tasks-with the advantage that they don't need coffee or sleep breaks. In fact, leading AI researchers believe that there is a 50% chance that machines will outperform humans in all tasks in 45 years (Grace et al., 2017) . The possibility that machines will one day replace physicians, at least in some specialties, like radiology, seems therefore very real to some. But the immediate challenge is to integrate AI, and in particular, computer vision, with existing workforce and structures rather than replacing them. So for the time being, anyway, you will probably still have to keep your hand near the wheel of your Tesla.
